Legend Biotech (FRA:9LB) Shares Buyback Ratio % : -10.16 (As of Jun. 02, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Legend Biotech's current shares buyback ratio was -10.16%.

Legend Biotech Shares Buyback Ratio % Historical Data

The historical data trend for Legend Biotech's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Shares Buyback Ratio % Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-29.08

-2.82

-15.96

-7.03

-10.20

Legend Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-0.24	-9.60	-0.51	0.21	-0.20

Legend Biotech Shares Buyback Ratio % Calculation

Legend Biotech's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(165.067	-	181.911)	/	165.067
	=	-10.20%

Legend Biotech's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Mar. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(181.911	-	182.283)	/	181.911
	=	-0.20%

Legend Biotech Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Legend Biotech's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech (FRA:9LB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (FRA:9LB) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

LEGN:USA

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.

Legend Biotech (FRA:9LB) Headlines

No Headlines